TREATMENT OF FABRY DISEASE IN ERT-NAÏVE AND ERT-EXPERIENCED PATIENTS

• 收藏
• 分享

专利权人:

INC.;AMICUS THERAPEUTICS

发明人:

CASTELLI, Jeff

申请号：

SG11202000423X

公开号：

SG11202000423XA

申请日:

2017.07.19

申请国别(地区):

SG

年份:

2020

代理人:

摘要：

Provided are dosing regimens for the treatment of Fabry disease in a patient. Certain methods relate to the treatment of ERT-experienced or ERT-nave Fabry patients. Certain methods comprise administering to the patient about 123 mg free base equivalent of migalastat for improving left ventricular mass and/or improving podocyte globotriaosylceramide.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/